Back to UBS Group AG UBS Group AG

TAKTAK
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in TAKEDA PHARMACEUTICAL CO LTD

UBS Group AG holds 2.7M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $50.7M as of 2026-Q1. The position was decreased (-33.5% shares). TAK represents 0.0% of UBS Group AG's portfolio.

Current Value

$50.7M

Current Shares

2.7M

Total Value Change

+$49.3M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.7M
-33.5%
$50.7M0.0%$18.08
0
2025-Q4
Decreased
4.1M
-30.0%
$64.3M0.0%$15.63
0
2025-Q3
Increased
5.9M
+46.5%
$86.3M0.0%$14.62
41
2025-Q2
Increased
4M
+129.4%
$62.2M0.0%$15.10
48
2025-Q1
Increased
1.8M
+5.6%
$26.1M0.0%$14.71
30
2024-Q4
Increased
1.7M
+2175.7%
$22M0.0%$12.87
46
2024-Q3
Decreased
73,015
-36.2%
$1M0.0%$13.89
0
2024-Q2
Increased
114,471
+19.0%
$1.5M0.0%$12.36
30

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used